We evaluated the cytotoxic activity of anti-B7-H3 CAR-T cells against two B7-H3-expressing cell lines, LAN-1 (neuroblastoma) and 143B (osteosarcoma), at varying effector-to-target ratios. Here, CD276 is linked to neuroblastoma.